Nagla Abdel Karim
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Nagla Abdel Karim sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).
Nagla Abdel Karim: 1 sponsored US clinical trial, none currently recruiting.
Nagla Abdel Karim sponsors 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Uterine Cervical Cancer, with 1 trials.
Mid-pack sponsor footprint
Nagla Abdel Karim is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.
Indexed trials (enrollment closed)
1 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
How the Nagla Abdel Karim early-phase archive is shaped
1 indexed studies, none listed as recruiting (0% open); 1 completed (100%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Uterine Cervical Cancer (1 trial), 7 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Nagla Abdel Karim: archived-pipeline peers nationwide
Peers matched on 1 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Nagla Abdel Karim sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1 archived trials
- 1200 Pharma · 2 trials · 50% recruiting
- 1ST Biotherapeutics · 2 trials · 50% recruiting
- 3 Waves Wellness · 2 trials · 0% recruiting
- 3EO Health · 2 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Nagla Abdel Karim page
1 registered trials is a research-attention snapshot, not an endorsement of Nagla Abdel Karim or any single study.
- None of Nagla Abdel Karim's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Uterine Cervical Cancer is the condition Nagla Abdel Karim studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Uterine Cervical Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Nagla Abdel Karim pipeline card: 1 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.